TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study

INTRODUCTION: The interaction between angiotensin-converting enzyme 2 (ACE2) and SARS-CoV-2 is a crucial factor in the viral infections leading to the release of inflammatory proteins, such as TNF-α. Thus, it is hypothesized that TNF-α blockers can prevent either COVID-19 incidence or its serious sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Salesi, Mansour, Shojaie, Behrokh, Farajzadegan, Ziba, Salesi, Naghmeh, Mohammadi, Erfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299175/
https://www.ncbi.nlm.nih.gov/pubmed/34297311
http://dx.doi.org/10.1007/s40744-021-00342-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299175/
https://www.ncbi.nlm.nih.gov/pubmed/34297311
http://dx.doi.org/10.1007/s40744-021-00342-8

Ejemplares similares